联合治疗

United Therapeutics: Bollinger Bands Narrowing, KDJ Death Cross on 15min Chart

United Therapeutics EVP Mahon Paul A Buys 8300 Shares, Sells 7,300 Shares at Various Prices

United Therapeutics's 15min Chart Shows MACD and KDJ Death Crosses

United Therapeutics' 15-Min Chart Triggers MACD Death Cross, KDJ Death Cross

United Therapeutics

Ptc Therapeutics

Axsome Therapeutics

Small-cap pharmaceuticals to watch: Tyvaso, Axsome, and Exelixis.

Catalyst<ul> <li>A recent MACD Golden Cross signal on February 3 suggests potential for a rebound in UTHR.</li> <li>Analysts have rated UTHR as Strong Buy, indicating broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show the market is in a volatile state with an unclear direction, suggesting caution for UTHR.</li> <li>Fund flow analysis indicates that most buckets show negative inflow trends, which may signal investor uncertainty or caution.</li></ul>

Key Factors

Executive Vice President and General Counsel Paul A. Mahon of United Therapeutics purchased 8,300 shares at $146.03 per share and sold 5,899 shares at various prices ranging from $480.92 to $485.52 per share on February 5, 2026.

Recent Updates

UTHR News